Zacks Investment Research
23 Oct 2026, 22:50 UTC · 1h ago
Here's Why Amgen (AMGN) Fell More Than Broader Market
Impact · against what's priced in
The article provides no new material catalysts for Amgen, as the projected earnings and revenue for the November 3rd report are consistent with the company's already reflected full-year guidance. The stock's recent price action remains tied to established expectations for legacy erosion and growth targets.
- AMGN+0.00
Already priced in
- The price assumes
The raised full-year revenue guidance of $38.2-$39.4 billion and non-GAAP EPS of $22.30-$23.50 are fully reflected.
The projected full-year revenue of $38.85 billion and earnings of $22.94 per share fall squarely within the guidance ranges the market has already absorbed.
What AMGN's price assumes · Sep 12
